Status:
UNKNOWN
Ovarian Tissue Freezing For Fertility Preservation
Lead Sponsor:
Oregon Health and Science University
Conditions:
Malignancy
Fertility
Eligibility:
FEMALE
18-41 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to offer an alternative method to women who wish to preserve the possibility of fertility, as well as to learn more about the ability of human eggs to survive and function...
Detailed Description
Women who have not yet undergone this procedure, and who present to the Fertility Consultants desiring fertility preservation, will be offered participation in the study. Subjects will undergo an ini...
Eligibility Criteria
Inclusion
- Woman between the age of 18-41 years who will undergo surgery, chemotherapy, drug treatment and/or radiation for the treatment or prevention of a medical condition or malignancy expected to result in permanent and complete loss of subsequent ovarian function or have a medical condition or malignancy that requires removal of all or part of one or both ovaries.
- Patients may have newly diagnosed or recurrent disease. Those who were not enrolled at the time of initial diagnosis are eligible if they have not received therapy that is viewed as likely to result in complete and permanent loss of ovarian function.
- For patients undergoing elective removal of an ovary for fertility preservation only, have two ovaries.
- Patients who already have stored cryopreserved ovarian tissue in a frozen state prior to undergoing cancer treatments (surgery, chemotherapy or radiation) will be eligible for enrollment with informed consent.
- Signed an approved informed consent and authorization permitting the release of personal health information. The patient and/or the patient's legally authorized guardian must acknowledge in writing that consent for specimen collection has been obtained, in accordance with institutional policies approved by the U.S. Department of Health and Human Services.
Exclusion
- Women with psychological, psychiatric, or other conditions which prevent giving fully informed consent.
- Women whose underlying medical condition significantly increases their risk of complications from anesthesia and surgery.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00902720
Start Date
May 1 2009
End Date
March 1 2025
Last Update
July 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health and Sciences Universtiy
Portland, Oregon, United States, 97239